The Semi Automated Coagulation Analyzer is a semi-automatic instrument which can measure the coagulation characteristics of blood

Due to the COVID-19 pandemic, the global Semi Automated Coagulation Analyzer market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Semi Automated Coagulation Analyzer market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Semi Automated Coagulation Analyzer landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Benchtop accounting for % of the Semi Automated Coagulation Analyzer global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Semi Automated Coagulation Analyzer include Genrui Biotech Inc., Horiba, Erba Group(ERBA Diagnostics Mannheim), Human, Meril Life Sciences, TECO Medical Instruments, A & T Corporation, Maccura Biotechnology and Dialab, etc. In terms of revenue, the global 3 largest players have a % market share of Semi Automated Coagulation Analyzer in 2021.

This report focuses on Semi Automated Coagulation Analyzer volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Semi Automated Coagulation Analyzer market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Global Semi Automated Coagulation Analyzer Market: Segment Analysis

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.


Segment by Type


Benchtop

Handheld


Segment by Application


Hospitals

Research Institutes

Diagnostic Centers

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E


By Company


Genrui Biotech Inc.

Horiba

Erba Group(ERBA Diagnostics Mannheim)

Human

Meril Life Sciences

TECO Medical Instruments

A & T Corporation

Maccura Biotechnology

Dialab

iLine Microsystems

Cypress Diagnostics

Succeeder